BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26019430)

  • 21. AUTOIMMUNE LIMBIC ENCEPHALITIS (CASE REPORTS).
    Kobaidze K; Harrison A; Burklin Y; Patidar V; Riccardi M
    Georgian Med News; 2017 May; (266):69-74. PubMed ID: 28628018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-complex antibody-associated limbic encephalitis.
    Wagner J; Schoene-Bake JC; Witt JA; Helmstaedter C; Malter MP; Stoecker W; Probst C; Weber B; Elger CE
    Epilepsia; 2016 Mar; 57(3):475-83. PubMed ID: 26749370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression.
    Triplett J; Vijayan S; MacDonald A; Lawn N; McLean-Tooke A; Bynevelt M; Phatouros C; Chemmanam T
    J Neuroimmunol; 2018 Oct; 323():119-124. PubMed ID: 30196824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
    Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
    Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?
    Blanc F; Ruppert E; Kleitz C; Valenti MP; Cretin B; Humbel RL; Honnorat J; Namer IJ; Hirsch E; Manning L; de Seze J
    J Neurol Sci; 2009 Dec; 287(1-2):69-71. PubMed ID: 19786284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET-positive extralimbic presentation of anti-glutamic acid decarboxylase antibody-associated encephalitis.
    Kojima G; Inaba M; Bruno MK
    Epileptic Disord; 2014 Sep; 16(3):358-61. PubMed ID: 25042574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
    Baizabal-Carvallo JF
    J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
    Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
    J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
    Mirabelli-Badenier M; Morana G; Pinto F; Uccelli A; Veneselli E; Battaglia FM; Biancheri R; Baglietto MG; Vincent A; Mancardi MM
    Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders.
    Sunwoo JS; Chu K; Byun JI; Moon J; Lim JA; Kim TJ; Lee ST; Jung KH; Park KI; Jeon D; Jung KY; Kim M; Lee SK
    J Neuroimmunol; 2016 Jan; 290():15-21. PubMed ID: 26711563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: Causality or coincidence?
    Niehusmann P; Widman G; Eis-Hübinger AM; Greschus S; Robens BK; Grote A; Becker AJ
    Neuropathology; 2016 Aug; 36(4):376-80. PubMed ID: 27431532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
    Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
    Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limbic encephalitis in Taiwanese children and adolescence: a single center study.
    Chou IJ; Wang HS; Lin JJ; Kuo CF; Lin KL; Chou ML; Hung PC; Hsieh MY; Lin YT;
    Pediatr Neonatol; 2013 Aug; 54(4):246-53. PubMed ID: 23597520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successfully treated anti-GAD limbic encephalitis in a 15-year-old diabetic boy with intravenous immunoglobulin: case report.
    Fattahzadeh Ardalani G; Samady Khanghah A; Jahanpanah M; Mokhtari D; Samady Khanghah P
    Ann Med Surg (Lond); 2024 Feb; 86(2):1173-1181. PubMed ID: 38333287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
    Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
    Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy.
    Lopez-Sublet M; Bihan H; Reach G; Dupont S; Didelot A; Mourad JJ; Krivitzky A; Dhote R
    Diabetes Metab; 2012 Jun; 38(3):273-5. PubMed ID: 22463975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long latency between GAD-antibody detection and development of limbic encephalitis--a case report.
    Fauser S; Uttner I; Ariño H; Scherbaum WA; Saiz A; Lewerenz J
    BMC Neurol; 2015 Sep; 15():177. PubMed ID: 26420440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports.
    Sarva H; Deik A; Ullah A; Severt WL
    Tremor Other Hyperkinet Mov (N Y); 2016; 6():340. PubMed ID: 26989571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
    Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
    Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.